Bio-Convert Receives Positive Feedback from The Danish Medicine Agency (DKMA) on its Lead Drug Candidate, QR-02 for Oral Leukoplakia
About Bio-Convert Bio-Convert’s mission is to develop the preferred treatment for oral leukoplakia. Our innovative therapeutic agent, QR-02, uses a novel drug delivery technology, that enables more ...
Cabral Gold Drills 12m @ 27.7g/t Gold at the Machichie NE Target, Cuiú Cuiú Gold District, Brazil
RC520 drilled at the Machichie NE target returned 12m @ 27.7 g/t gold from 42m depth in saprolite and weathered and altered bedrock including 5m @ 65.5 g/t gold from 49m depth. This interval is ...